Aranax Medical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
- Revenue Growth -9.16%
- Profit Growth 14.25%
- Ebitda 12.40%
- Net Worth 106.74%
- Total Assets 77.66%
About Aranax Medical
Aranax Medical Private Limited (AMPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 26 May 2017 (Seven years and eight months 27 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Alok Sharma, Anshul Sharma, and Ashish Sharma serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33309RJ2017PTC058133
- Company No.
058133
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
What products or services does Aranax Medical Private Limited offer?
Aranax Medical Private Limited offers a wide range of products and services, including IVDs & Analyzers, Electrolyte Analyzer, Medical Laboratory Instruments, Blood Gas Analyzer.
Who are the key members and board of directors at Aranax Medical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anshul Sharma  | Director | 26-May-2017 | Current |
| Alok Sharma | Director | 26-May-2017 | Current |
| Ashish Sharma | Director | 26-May-2017 | Current |
Financial Performance of Aranax Medical.
Aranax Medical Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.16% decrease. The company also saw a substantial improvement in profitability, with a 14.25% increase in profit. The company's net worth Soared by an impressive increase of 106.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aranax Medical?
In 2023, Aranax Medical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2023 | Others | ₹1.00 Cr | Open |
How Many Employees Work at Aranax Medical?
Unlock and access historical data on people associated with Aranax Medical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aranax Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aranax Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.